Crist Sarah B, Ghajar Cyrus M
Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA; email:
Program in Molecular and Cellular Biology, University of Washington, Seattle, Washington 98105, USA.
Annu Rev Pathol. 2021 Jan 24;16:409-432. doi: 10.1146/annurev-pathmechdis-012419-032647. Epub 2020 Dec 4.
Over the last four decades, the cancer biology field has concentrated on cellular and microenvironmental drivers of metastasis. Despite this focus, mortality rates upon diagnosis of metastatic disease remain essentially unchanged. Would a small change in perspective help? Knowing what constitutes an inhospitable, rather than hospitable, microenvironment could provide the inspiration necessary to develop better therapies and preventative strategies. In this review, we canvas the literature for hints about what characteristics four common antimetastatic niches-skeletal muscle, spleen, thyroid, and yellow bone marrow-have in common. We posit that thorough molecular and mechanistic characterization of antimetastatic tissues may inspire reimagined therapies that inhibit metastatic development and/or progression in an enduring manner.
在过去的四十年里,癌症生物学领域一直专注于转移的细胞和微环境驱动因素。尽管有此关注重点,但转移性疾病诊断后的死亡率基本保持不变。视角上的微小改变会有所帮助吗?了解构成不适合而非适合肿瘤生长的微环境的因素,可能会为开发更好的治疗方法和预防策略提供必要的灵感。在这篇综述中,我们在文献中探寻线索,以了解四种常见的抗转移生态位——骨骼肌、脾脏、甲状腺和黄骨髓——有哪些共同特征。我们认为,对抗转移组织进行全面的分子和机制表征,可能会激发人们重新构想以持久方式抑制转移发展和/或进展的治疗方法。